Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CB1R ARRESTIN

Financiado

Cerrado

Contribution of beta arrestin dependent receptor signaling to the physiological...

Contribution of beta arrestin dependent receptor signaling to the physiological regulation of the endocannabinoid system The endocannabinoid system is composed of endocannabinoids, such as anandamide and 2-arachidonoylglycerol (2-AG), their metabolizing enzymes and cannabinoid receptors. To date, two cannabinoid receptors have been identified by mol... ver más

28/02/2015

SEMMELWEIS UNIVERS...

224K€

Presupuesto del proyecto: 224K€

Líder del proyecto

SEMMELWEIS EGYETEM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-02-28 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

SEMMELWEIS UNIVERSITY

0.00€ | Lider

Proyectos interesantes

PID2020-116579RB-I00

Medical Technol...

Applied Physics

145K€ Cerrado

SAF2009-07309

Medical Technol...

Applied Physics

109K€ Cerrado

RTI2018-095311-B-I00

Medical Technol...

Applied Physics

399K€ Cerrado

SAF2015-64945-R

Medical Technol...

Applied Physics

399K€ Cerrado

PID2021-125118OB-I00

Medical Technol...

Applied Physics

327K€ Cerrado

SAF2009-07065

Medical Technol...

Applied Physics

121K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

SEMMELWEIS EGYETEM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 224K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The endocannabinoid system is composed of endocannabinoids, such as anandamide and 2-arachidonoylglycerol (2-AG), their metabolizing enzymes and cannabinoid receptors. To date, two cannabinoid receptors have been identified by molecular cloning, the CB1 and CB2 receptors. The endocannabinoid system has been implicated in a number of physiological functions, and pharmacological manipulation of this system is a promising therapeutic target in a large number of different diseases and conditions, including mood and movement disorders, obesity, neuropathic pain and cancer, etc. In neurons, release of endocannabinoids can be initiated by calcium signal or by stimulation of G-protein-coupled receptors (GPCRs). Anandamide production may be regulated by a number of lipid modulating enzymes, whereas 2-AG is produced by diacylglycerol-lipases (DAGLs). Stimulation of AT1 angiotensin II receptor and other Gq-coupled-receptors leads to DAGL dependent production of endocannabinoids, but the exact mechanism of this response has not been elucidated. The mechanism of action of GPCRs involves both G-protein-dependent and -independent pathways. G-protein-independent pathways are mediated by beta-arrestin-dependent scaffolding and regulation of signaling complexes. Although the role of these proteins during AT1R signaling is well documented, their function in the G-protein independent signaling of CB1R is not known. The aim of the present project is to elucidate the role of beta-arrestin mediated signaling in the regulation of endocannabinoid production, and to elucidate the role of G-protein-independent signaling in CB1R function. The proposed project includes in vitro studies using molecular biology techniques and in vivo experiments using genetically altered mouse models to elucidate these questions.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores